TITAN PHARMACEUTICALS INC DE's ticker is and the CUSIP is 888314906. A total of 2 filers reported holding TITAN PHARMACEUTICALS INC DE in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3 | -99.9% | 4,700 | -2.1% | 0.00% | – |
| Q3 2022 | $5,000 | +25.0% | 4,800 | +11.6% | 0.00% | – |
| Q4 2021 | $4,000 | -71.4% | 4,300 | -21.8% | 0.00% | – |
| Q3 2021 | $14,000 | 0.0% | 5,500 | -1.8% | 0.00% | – |
| Q2 2021 | $14,000 | -62.2% | 5,600 | +4309.4% | 0.00% | – |
| Q1 2021 | $37,000 | -76.0% | 127 | -73.0% | 0.00% | – |
| Q4 2020 | $154,000 | – | 471 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |